Alpha Tau Medical shares are trading lower. The company announced overall survival and safety results from a pooled analysis of three prospective Phase I/II clinical studies evaluating endoscopic ultrasound-guided intratumoral Alpha DaRT treatment...

Alpha Tau Medical Ltd

Alpha Tau Medical Ltd

DRTS

0.00

Alpha Tau Medical shares are trading lower. The company announced overall survival and safety results from a pooled analysis of three prospective Phase I/II clinical studies evaluating endoscopic ultrasound-guided intratumoral Alpha DaRT treatment in patients with pancreatic ductal adenocarcinoma.